Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Zscaler to Host Innovations Briefing for Investors at Zenith Live 2025
-
The Australian Creed for Sexual Integrity: Truth in a Time of Compromise
-
ORYZON to Provide Corporate Progress Updates at Several Events in May-June
-
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN
-
Check Point to Acquire Veriti to Transform Threat Exposure Management and Reduce Organizations’ Cyber Attack Surface
-
NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
-
BC Real Estate Association Calls for New Short-Term Rental Exemptions Amidst Tariff Challenges and Expected High Tourism Demand
-
Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025
-
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.
-
Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
-
Elevate Mental Health Expands Access to Online Psychiatry and Behavioral Health Services Across Texas
-
Cajo Technologies Secures Investment to Accelerate Global Expansion of Sustainable Laser Marking Solutions
-
Liz Buys Houses Celebrates Achieving Five-Star Reviews as Homeowners Nationwide Rave About Fast, Fair Cash Offers
-
Reflect Scientific, Inc. Announces Strategic Cost-Cutting Initiative to Reduce SG&A Expenses by Up to 35% in 2025
-
Immutep’s Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
-
German Car Depot Publishes New Article on ‘BMW Repair Services: Expert Care for Your Ultimate Driving Machine’
-
Lightbridge Outlines Opportunities Created by President Trump's Nuclear Executive Orders
-
Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
-
Palvella Therapeutics Strengthens Executive Leadership Team with Appointment of Rare Disease Commercial Veteran Ashley Kline as Chief Commercial Officer
-
Seanergy Maritime Reports Financial Results for the Quarter Ended March 31, 2025 and Declares Cash Dividend of $0.05 Per Share
-
Ascent Solar Technologies Signs Master Services Agreement to Provide NOVI Space with Rollable PV Array Blankets for Launch in 2026
-
Final Settlement of Computing Power Loss! KixaMiner Launches Intelligent Chain Scheduling System with Millisecond-Level Optimal Mining Protocol Switching
-
MicroAlgo Inc. Explores Optimization of Quantum Error Correction Algorithms to Enhance Quantum Algorithm Accuracy
-
SharpLink Gaming Announces $425,000,000 Private Placement to Initiate Ethereum Treasury Strategy
-
LIS Technologies Inc. Appoints Leading Regulatory Expert Julie Olivier as its Regulatory Affairs and Licensing Director
-
Super League Announces Exclusive Partnership with AdArcade to Bring High-Performing Native Playable™ Ads to Brands and Media Agencies at Scale Across Mobile Games
-
Junshi Biosciences Announces Ongericimab’s sNDA Approval in China
-
Verizon to speak at Bernstein conference May 29
-
LENZ Therapeutics to Present at Upcoming Investor Conferences
-
Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
-
Hydreight Launches Personalized Genetic Testing and Wellness Solution on VSDHOne Platform
-
Multi Ways Holdings Reports Financial Results for Fiscal Year 2024
-
Immutep’s Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
-
Veterans-Turned-Tradesmen Use Their Craftsmen Skills and Tools at Hand To Fight Crime and Terrorism On American Soil In Newly Published Action Thriller
-
DeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns Journal
-
Intrado Launches Public Safety Advisory Council to Guide Innovation in 9-1-1 and Emergency Response
-
Emory Healthcare Researchers Use Dynamic Digital Radiography to Compare Shoulder Improvement of Two Surgical Interventions for Massive Irreparable Rotator Cuff Tears
-
authID Announces its 2025 Board of Directors Nominees Ahead of Annual Meeting
-
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
-
Merus to Present at Upcoming Investor Conferences
-
ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC
-
NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
-
Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025
-
New Study Reveals Agriculture as Largest, Most Resource-Intensive Industry on Earth
-
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
-
Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for FLT201, its Clinical-Stage Gene Therapy Candidate in Gaucher Disease
-
MIMEDX to Participate in Upcoming Investor Conferences
-
Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025
-
SSCP Lager Bidco AB (publ) – Interim report for first quarter 2025
-
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Completion of Enrollment of the Global Phase 2b Study Evaluating Naronapride in Gastroparesis (MOVE-IT)
